Market research
14K.F Sundial Growers Inc
F EUR Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 661M
- P/E ratio
- Not available
- Analyst target
- 0.7
- Dividend yield
- 0.0%
- Beta
- 4.87
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- Not available
- Market cap
- 661M
- P/E ratio
- Not available
- Analyst target
- 0.7
- Dividend yield
- 0.0%
- Beta
- 4.87
About
About Sundial Growers Inc
Sundial Growers Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. Sundial Growers Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
Research context
Sundial Growers Inc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 14K.F discussion.
5 years, 6 months ago
Sundial Growers Inc is currently in a long term uptrend where the price is trading 11.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.
Sundial Growers Inc's total revenue sank by 35.7% to $14M since the same quarter in the previous year.
Its net income has increased by 55.8% to $-64M since the same quarter in the previous year.
Finally, its free cash flow grew by 84.8% to $-12M since the same quarter in the previous year.
Based on the above factors, Sundial Growers Inc gets an overall score of 4/5.